MedPath

沈阳管城制药有限责任公司

Ownership
-
Established
2001-06-06
Employees
-
Market Cap
-
Website
http://www.sygczy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

92

NMPA:92

Drug Approvals

Amlodipine Besilate Tablets

Product Name
苯磺酸氨氯地平片
Approval Number
国药准字H20084575
Approval Date
May 10, 2023
NMPA

Azithromycin Dispersible Tablets

Product Name
阿奇霉素分散片
Approval Number
国药准字H20083927
Approval Date
Mar 23, 2023
NMPA

红药片

Approval Number
国药准字Z20064187
Approval Date
Jun 17, 2021
NMPA

鸦胆子油口服乳液

Approval Number
国药准字Z21020895
Approval Date
Jan 27, 2021
NMPA

壮阳春口服液

Approval Number
国药准字Z21021040
Approval Date
Jan 27, 2021
NMPA

小建中合剂

Approval Number
国药准字Z21021039
Approval Date
Jan 27, 2021
NMPA

仙茸壮阳口服液

Approval Number
国药准字Z21021037
Approval Date
Jan 27, 2021
NMPA

Paracetamol Tablets

Product Name
对乙酰氨基酚片
Approval Number
国药准字H21020452
Approval Date
Jul 13, 2020
NMPA

Oryzanol Tablets

Product Name
谷维素片
Approval Number
国药准字H21021270
Approval Date
Jul 13, 2020
NMPA

Fosfomycin Calcium Capsules

Product Name
磷霉素钙胶囊
Approval Number
国药准字H21024106
Approval Date
Jul 13, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 10
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.